Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to David B Badesch

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Badesch, David

Item TypeName
Academic Article A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
Academic Article Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension.
Academic Article Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
Academic Article The pressure-overloaded right ventricle in pulmonary hypertension.
Academic Article Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.
Academic Article Survival with first-line bosentan in patients with primary pulmonary hypertension.
Academic Article Ambrisentan therapy for pulmonary arterial hypertension.
Academic Article Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Academic Article Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress.
Academic Article ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
Academic Article Diagnosis and assessment of pulmonary arterial hypertension.
Academic Article Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension.
Academic Article Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
Academic Article The study of risk in pulmonary arterial hypertension.
Academic Article Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.
Academic Article Beraprost therapy for pulmonary arterial hypertension.
Academic Article Importance of angiotensin-converting enzyme in pulmonary hypertension.
Academic Article Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.
Academic Article Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
Academic Article Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Academic Article End points and clinical trial design in pulmonary arterial hypertension.
Academic Article Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Concept Hemodynamics
Academic Article Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
Academic Article Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
Academic Article Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
Academic Article Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
Academic Article Five-Year outcomes of patients enrolled in the REVEAL Registry.
Grant RELATIVE ARGININE DEFICIENCY IN PULMONARY HYPERTENSION
Grant HYPERTENSIVE PULMONARY VASCULAR REMODELING--ROLE OF IGF
Academic Article Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.

Search Criteria
  • Hemodynamics

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)